WASHINGTON (AP) — GlaxoSmithKline is recalling a popular four-in-one flu vaccine distributed throughout the U.S. because its effectiveness can decline over time.
The company alerted customers Tuesday that the vaccine can lose potency and fail to adequately protect against some flu strains. The Flulaval Quadrivalent Thimerosal-free vaccine in prefilled syringes is designed to protect against four strains of influenza virus. But Glaxo said it "cannot rule out ...
21:57 Tesla: The Bill Is Still Coming Due3
21:11 AT&T defends Time Warner merger, announces $35 DirecTV streaming15
16:36 AT&T, Time Warner poised to lobby lawmakers, regulators on proposed $85-billion merger23
10:57 CMO Today: AT&T’s Ambitious Advertising Plans With Time Warner Deal32